IGF‐1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Schwann cell (SC) differentiation to the myelinating phenotype is characterized by the elaboration of a lipid‐rich membrane and the expression of myelin‐specific proteins. Insulin‐like growth factor‐1 (IGF‐1) has been identified as a growth factor that stimulates the early events of myelination in SCs that signals via the PI3K/Akt pathway. Given the role of IGF‐1 in promoting myelination, we performed studies to determine if the fatty acid biosynthetic pathway was a target of IGF‐1 signaling in the formation of myelin membrane in dorsal root ganglion neuron/Schwann cell (DRG/SC) cocultures. We report that the fatty acid profile of lipid extracts of cocultures treated with IGF‐1 match that reported for native myelin membrane by electrospray mass spectroscopy analysis. We also demonstrate de novo fatty acid biosynthesis in response to IGF‐1 treatment in DRG/SC cocultures metabolically labeled with 13 C‐acetate as a carbon source for fatty acid synthesis. Consistent with this finding, Western blot analysis of lysates from both cocultures and purified SCs reveal that IGF‐1 stimulates two key fatty acid synthesizing enzymes. Additionally, we show that stimulation of fatty acid synthesizing enzymes is mediated by the PI3K/Akt signaling pathway. We also show that the fatty acid synthesizing enzymes and associated signaling pathways are elevated during the period of myelin membrane formation in sciatic nerve. Collectively, these findings demonstrate that IGF‐1 plays an important regulatory function during myelin membrane formation. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beck, K. D., Powell-Braxtont, L., Widmer, H.-R., Valverde, J., & Hefti, F. (1995) · Neuron · doi:10.1016/0896-6273(95)90216-3 · Cited by 636 · cited 1×
“…mechanism in SCs. IGF-1 as a stimulus for myelin formation has been demonstrated in DRG/SC cocultures and in vivo using IGF-1 transgenic mice either overexpressing or deficient in IGF-1 (Beck et al., 1995; Cheng et al., 1999; Ogata et al., 2004; Russell et al., 2000; Ye et al., 1995, 2002).”
BackgroundThe identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes
Berwick, D. C., Hers, I., Heesom, K. J., Moule, S. K., & Tavareá, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204681200 · Cited by 383 · cited 5×
“Phosphorylation of ACL at the Ser454 residue increases the catalytic activity of this enzyme (Berwick et al., 2002; Potapova et al., 2000; Wang and Sul, 1998).”
BackgroundInfluentialIdentification of Genes Induced in Peripheral Nerve after Injury
Araki, T., Nagarajan, R., & Milbrandt, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104271200 · Cited by 76 · cited 2×
“In response to nerve injury, SCs dedifferentiate and expand into phenotypically immature SCs and are associated with the upregulation of a host of proteins including growth factors, receptors, and adhesion molecules (Araki et al., 2001; Kubo et al., 2002).”
Background
Cited by
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
“…ApoE, metal chelators (including apotransferrin), eurotrophins that have promyelinating effect (such as IGF1, erve growth factor, and insulin) (Liang et al., 2007; Zeger t al., 2007) (reviewed in Chesik et al., 2008) may be possile through intranasal administration (Benedict et al., 2004; e…”
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
M. de la Monte, S. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 448
Constitutively active Akt induces enhanced myelination in the CNS
Flores, A. I., Narayanan, S. P., Morse, E. N., Shick, H. E., Yin, X., Kidd, G., Avila, R. L., Kirschner, D. A., & Macklin, W. B. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0150-08.2008 · Cited by 361
Goebbels, S., Oltrogge, J. H., Kemper, R., Heilmann, I., Bormuth, I., Wolfer, S., Wichert, S. P., Mobius, W., Liu, X., Lappe-Siefke, C., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0219-10.2010 · Cited by 347
Type 3 diabetes is sporadic Alzheimer׳s disease: Mini-review
de la Monte, S. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.008 · Cited by 313
Treatment strategies against diabetes: Success so far and challenges ahead.
Khursheed, R., Singh, S. K., Wadhwa, S., Kapoor, B., Gulati, M., Kumar, R., Ramanunny, A. K., Awasthi, A., & Dua, K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172625 · Cited by 239
Zhang, W. B., Aleksic, S., Gao, T., Weiss, E. F., Demetriou, E., Verghese, J., Holtzer, R., Barzilai, N., & Milman, S. (2020) · Cells · doi:10.3390/cells9061368 · Cited by 64
Metadata
- Authors
- Liang, G., Cline, G. W., & Macica, C. M.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2007-02-13
- Volume
- 55
- Issue
- 6
- Pages
- 632-641
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2075082524
- Cited by
- 79
- References
- 3
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.